Benefit of the high-dose influenza vaccine

Since last year, a high-dose influenza vaccine has been available in Switzerland in addition to the standard vaccines, which is recommended and approved for people over 75 and for people aged 65 and over with an additional risk factor. Empirical data confirm the higher efficacy of quadrivalent high-dose compared to quadrivalent standard-dose influenza vaccines in these age groups.